Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$98.98 - $115.74 $5,641 - $6,597
-57 Reduced 2.1%
2,658 $307,000
Q2 2023

Jul 25, 2023

SELL
$96.34 - $112.38 $36,898 - $43,041
-383 Reduced 12.36%
2,715 $279,000
Q1 2023

Apr 14, 2023

SELL
$107.32 - $113.5 $7.68 Million - $8.12 Million
-71,537 Reduced 95.85%
3,098 $338,000
Q4 2022

Feb 08, 2023

SELL
$62.39 - $113.8 $114,236 - $208,367
-1,831 Reduced 2.39%
74,635 $8.49 Million
Q3 2022

Oct 25, 2022

BUY
$58.92 - $84.67 $24,451 - $35,138
415 Added 0.55%
76,466 $4.73 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $58,597 - $85,873
-738 Reduced 0.96%
76,051 $6.07 Million
Q1 2022

May 11, 2022

SELL
$86.42 - $109.81 $1.18 Million - $1.5 Million
-13,616 Reduced 15.06%
76,789 $8.08 Million
Q4 2021

Feb 08, 2022

BUY
$98.56 - $119.91 $687,061 - $835,892
6,971 Added 8.36%
90,405 $9.74 Million
Q3 2021

Nov 02, 2021

SELL
$91.91 - $110.37 $136,026 - $163,347
-1,480 Reduced 1.74%
83,434 $9.14 Million
Q2 2021

Aug 11, 2021

BUY
$86.24 - $95.92 $295,285 - $328,430
3,424 Added 4.2%
84,914 $7.95 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $1.84 Million - $2.45 Million
-25,622 Reduced 23.92%
81,490 $7.5 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $457,275 - $575,961
6,825 Added 6.81%
107,112 $7.84 Million
Q3 2020

Nov 04, 2020

SELL
$55.23 - $79.93 $174,416 - $252,418
-3,158 Reduced 3.05%
100,287 $7.79 Million
Q2 2020

Jul 17, 2020

BUY
$30.2 - $56.98 $51,219 - $96,638
1,696 Added 1.67%
103,445 $5.75 Million
Q1 2020

Apr 21, 2020

SELL
$24.87 - $38.56 $817,253 - $1.27 Million
-32,861 Reduced 24.41%
101,749 $3.01 Million
Q4 2019

Feb 12, 2020

SELL
$25.43 - $36.67 $77,968 - $112,430
-3,066 Reduced 2.23%
134,610 $4.87 Million
Q3 2019

Nov 07, 2019

BUY
$23.0 - $27.97 $8,464 - $10,292
368 Added 0.27%
137,676 $3.75 Million
Q2 2019

Aug 06, 2019

BUY
$22.81 - $28.48 $3.13 Million - $3.91 Million
137,308 New
137,308 $3.3 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.